Drug intelligence / Profile preview

yi-fei san-jie pill

Development stage
Unknown
Lead developer
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yi-Fei San-Jie Pill (YFSJ) is a traditional Chinese medicine formula widely used as an adjunctive therapy for non-small cell lung cancer (NSCLC), particularly in China. It is composed of multiple herbal ingredients and has been validated in clinical studies for its efficacy in NSCLC treatment[1][4]. YFSJ exerts anti-tumor effects through several mechanisms, including inhibition of epithelial-mesenchymal transition (EMT), suppression of tumor angiogenesis, promotion of apoptosis, and inhibition of cell proliferation[1][2][4]. Mechanistically, YFSJ targets key signaling pathways such as the EGFR/p-p38 MAPK/GSK3β axis and the PI3K/AKT pathway to suppress EMT and enhance sensitivity to targeted therapies like gefitinib[1][4]. Additionally, it alleviates chemotherapy-related fatigue by reducing oxidative stress and skeletal muscle injury via modulation of the AMPK/mTOR pathway[3][5]. The formula contains herbs such as Mao Zhua Cao (Herba Hedyotidis Diffusae), Shan Ci Gu (Bulbus Cremastrae seu Pleiones), and Ling Zhi (Ganoderma lucidum), which contribute to its anti-cancer properties by inhibiting tumor angiogenesis and supporting immune function[2].

Brand names
yi-fei san-jie pill
Other names
yifei sanjie pillyifei sanjie formulayfsjyfsjf
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on yi-fei san-jie pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yi-fei san-jie pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call